External ventricular drainage (EVD), also known as ventriculostomy or extraventricular drain, is a neurosurgical intensive care unit surgery. Using a ventricular drainage set, a ventriculostomy is performed to remove excess cerebrospinal fluid in order to measure and maintain intracranial pressure. In medical circumstances such as severe closed head injury, intracranial hypertension, intraventricular or subarachnoid haemorrhages, transitory occlusive hydrocephalus, and inflammatory illnesses of the cerebrospinal space, a ventricular drainage set is employed. Catheter, drainage bag, and monitor are included in the Ventricular Drainage Set. The rising prevalence of medical conditions that necessitate the use of ventricular drainage sets is likely to propel the ventricular drainage sets market forward over the forecast period.
Request Here Free Sample Copy of Report
Ventricular Drainage Sets Market Dynamics
The high incidence of intraventricular haemorrhage associated with premature baby birth is expected to boost the ventricular drainage sets market expansion. Intraventricular haemorrhage is prevalent in 15 percent to 20 percent of newborns born before 32 weeks of pregnancy, according to a study published in Child’s Nervous System in 2016. Furthermore, as the prevalence of neurological illnesses rises, demand for ventricular drainage sets rises, propelling the ventricular drainage sets market forward. The annual incidence of traumatic brain injury in the United States ranges from 1.4 million to 1.7 million, according to the American Neurological Association. The ventricular drainage set market is predicted to develop in response to rising vehicle accidents. Road accidents cause a high percentage of traumatic injuries in nations like India and China, which leads to an increase in demand for ventricular drainage sets. For instance, according to Government of India, in 2016, injuries, disabilities, and deaths caused by road accidents accounted for around 494,624 injuries, with 1,317 accidents per day.
Road injuries are also among the top 20 main causes of death worldwide, according to the Global Burden of Disease report. Furthermore, according to the World Health Organization (WHO), if road traffic crashes are not regulated, road injuries would become the seventh largest cause of death by 2030. New product approvals are also helping to boost the market for ventricular drainage sets. For example, Arkis BioScience, a pioneer and provider of minimally invasive surgical instruments and catheters, got FDA approval for CerebroFlo, a novel external ventricular catheter, in 2017. Complications associated with the use of ventricular drainage, on the other hand, are likely to be a key stumbling block to the market’s expansion. Infection and bleeding are the two most prevalent problems associated with external ventricular drains. Furthermore, the scarcity of qualified experts for neurosurgery increases the danger of infection and bleeding.
Ventricular Drainage Sets Market – Regional Analysis
North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa make up the global ventricular drainage sets market. The market for ventricular drainage sets in North America is projected to be dominating. This is due to an increase in demand caused by an increase in traumatic brain injury hospitalizations. For instance, according to Morbidity and Mortality Weekly Report (MMWR) Surveillance Summaries 2017, the rate of traumatic brain injury related emergency department visits in the U.S. increased by 47% whereas death rates decreased by 5%, over the duration of six years (2007–2013). The decrease in death rate is expected to be due to increasing adoption of medical equipment to better serve the patients.
Major companies operating in the global ventricular drainage sets market include Integra LifeSciences Corporation, Medtronic plc, Fuji Systems Corporation, Moller Medical GmbH, Sophysa, Dispomedica, and Spiegelberg GmbH & Co. KG.
Ventricular Drainage Sets Market – Taxonomy
Based on product type:
- Ventricular Drainage Set
- Accessories (catheters and external ventricular drainage bag)
Based on application:
- Intraventricular Hemorrhage
- Intracranial Hypertension
- Hydrocephalus
- CSF Infection
- Others
Based on end user:
- Hospitals
- Ambulatory Surgical Centers
Based on region:
- North America
- Europe
- Latin America
- Asia Pacific
- Middle East
- Africa
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact US:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837